NCT06699147

Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine S

Multicenter, Prospective, Observational Study to Evaluate the Post-marketing Efficacy and Safety of Eptq S and Eptq Lidocaine S Applied to the Facial Region

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 238 (actual)
• Sponsor: Jetema Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This study in multi-center, prospective and observational study. The purpose of this study is to observe effects and safety of hyaluronic acid filler series, eptq S and eptq Lidocaine S, for facial volume and folds.

Detailed description

Participants for this study are treated with eptq S and eptq Lidocaine S for smoothing nasolabial folds or volumizing mid-face or lips. Treating period is around 24 weeks. Facial volume and wrinkle condition, participants' satisfaction, and safety would be assessed.

Conditions

• Nasolabial Folds
• Mid Face Volume Loss
• Lip Volume Enhancement

Interventions

Type	Name	Description
DEVICE	Hyaluronic Acid (HA)	6 types of hyaluronic acid(HA) fillers that are differ in HA concentration and lidocaine were used for this study. Each type was applied to different condition or group depending on the investigators medical diagnosis

Timeline

• Start date: 2022-09-21
• Primary completion: 2022-12-05
• Completion: 2023-05-06
• First posted: 2024-11-21
• Last updated: 2024-11-21

Locations

1 site across 1 country: South Korea